Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Adults.

Autor: Bebb, D. Gwyn1 gwyn.bebb@ahs.ca, Banerji, Shantanu2 sbanerji@cancercare.mb.ca, Blais, Normand3 normand.blais.chum@ssss.gouv.qc.ca, Desmeules, Patrice4 patrice.desmeules@criucpq.ulaval.ca, Gill, Sharlene5 sgill@bccancer.bc.ca, Grin, Andrea6 andrea.grin@kingstonhsc.ca, Feilotter, Harriet6 hf4@queensu.ca, Hansen, Aaron R.7 aaron.hansen@uhn.ca, Hyrcza, Martin8 monika.krzyzanowska@uhn.ca, Krzyzanowska, Monika7 martin.hyrcza@albertaprecisionlabs.ca, Melosky, Barbara5 bmelosky@bccancer.bc.ca, Noujaim, Jonathan9 john.c.njm@gmail.com, Purgina, Bibiana10 bpurgina@toh.ca, Ruether, Dean11 dean.ruether@albertahealthservices.ca, Simmons, Christine E.5 christine.simmons@bccancer.bc.ca, Soulieres, Denis3 denis.soulieres.chum@ssss.gouv.qc.ca, Torlakovic, Emina Emilia12 emina.torlakovic@saskhealthauthority.ca, Ming-Sound Tsao13 ming.tsao@uhn.ca
Zdroj: Current Oncology. Feb2021, Vol. 28 Issue 1, p523-548. 26p.
Databáze: Academic Search Ultimate